Empowering Patients and Physicians

Carevala’s comprehensive RPM/CCM solutions are designed to cover a wide range of chronic conditions and preventative care needs, ensuring that your patients receive the care they need, when they need it. Learn how our data-driven, patient-centered approach can transform care for complex medical cases.

  • Hypertension, a key risk factor for cardiovascular disease (CVD), has been linked to dementia. The China Rural Hypertension Control Project (CRHCP), a groundbreaking study with over 33,000 participants, and the SPRINT Study of over 9000 patients found that intensive blood pressure (BP) lowering to <120 mmHg significantly reduces dementia and cognitive impairment risk. These pioneering findings, which you may not have been aware of, are highlighted on this page, along with an explanation of how Carevala’s Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform can help implement these strategies.

    Key Findings: Intensive Blood Pressure Lowering Reduces Dementia Risk

    • Reduced Dementia Risk: Targeting a systolic BP of <120 mmHg decreased the risk of all-cause dementia by 15%.

    • Reduced Cognitive Impairment: The risk of cognitive impairment without dementia (CIND) dropped by 16%.

    • Consistent Benefits: Benefits were consistent across various subgroups, including ages, sexes, education levels, and baseline cardiovascular risk factors.

    • Safety and Tolerability: There were no significant differences in serious adverse events, falls, or syncope, indicating that the intervention is safe and viable.

    These findings align with the Systolic Blood Pressure Intervention Trial (SPRINT), which showed similar benefits for major cardiovascular events and mortality reduction. SPRINT found that the lower target (less than 120 mm Hg) reduced cardiovascular events by 25 percent and the overall risk of death by 27 percent.

    Carevala’s RPM/CCM Solution: Optimizing Blood Pressure Control for Dementia Prevention

    Carevala’s RPM and CCM programs provide a comprehensive and robust approach to blood pressure management and dementia prevention, giving healthcare professionals the tools they need to make a difference. This comprehensive approach is designed to give you confidence in the platform’s capabilities.

    • Remote Blood Pressure Monitoring: Bluetooth-enabled BP monitors for accurate home tracking toward the <120 mmHg target.

    • Personalized Care Plans: Carevala’s individualized care plans incorporate intensive BP-lowering strategies tailored to each patient, ensuring that they feel valued and understood and receive the specific care they need.

    • Medication Adherence and Optimization: Ensures adherence to antihypertensive medications and dosage optimization based on real-time data.

    • Lifestyle Modification Support: Personalized guidance on diet, exercise, stress management, and other lifestyle changes to reduce BP and improve overall health.

    • Cognitive Assessment and Monitoring: Includes cognitive assessments to monitor signs of mental decline for timely intervention.

    Conclusion

    The CRHCP trial shows that intensive blood pressure lowering can significantly reduce the risks of dementia and cognitive impairment. Carevala’s RPM/CCM platform offers a comprehensive solution for implementing this strategy, empowering healthcare providers to optimize blood pressure control, monitor mental health, and improve long-term outcomes for patients with hypertension. Consider adopting our platform to enhance your practice.

    Contact Carevala to learn more about enhancing your approach to hypertension management and dementia prevention with our RPM/CCM platform.

  • Early Detection Proactive Management Carevala’s Advanced Atrial Fibrillation Solution

    Atrial fibrillation (AFib), a common heart rhythm disorder, significantly increases the risk of stroke and other serious health complications. Effective AFib management requires a multifaceted approach focused on early detection, stroke prevention, and addressing underlying risk factors.

    Key Takeaways

    • The Silent Threat: Many individuals with AFib are asymptomatic, underscoring the crucial role of proactive screening for early intervention. This vigilance can make a significant difference in patient outcomes.

    • Beyond Symptom Control: Optimal AFib management involves stroke risk assessment, appropriate anticoagulation therapy, and addressing modifiable risk factors.

    • Data-Driven Care: Continuous monitoring and real-time alerts are not just tools; they are your allies in the fight against AFib. They are essential for timely intervention and personalized treatment adjustments, empowering you to make informed decisions.

    Carevala's Comprehensive AFib Solution

    Carevala recognizes the pivotal role of healthcare professionals in AFib management. You are the frontline warriors in the battle against AFib, and we are here to support you. We provide a comprehensive, patient-centered solution that empowers you to make a difference, combining advanced RPM technology with personalized CCM support:

    • Multi-Modality Screening: Carevala offers various FDA-cleared ECG devices (KardiaMobile, Eko DUO, Vivalnk patches) to cater to individual patient needs and preferences.

    • Real-Time Detection and Alerts: Immediate notifications of AFib events empower patients and providers to take prompt action.

    • Risk Factor Management: RPM facilitates blood pressure, glucose, weight, and sleep monitoring, providing insights into modifiable risk factors. CCM offers targeted education and support for lifestyle changes.

    • Medication Adherence: RPM/CCM supports adherence to AFib medications, which is particularly crucial for anticoagulation therapy to minimize stroke risk.

    • Patient-Provider Collaboration: Carevala's RPM data and insights help facilitate shared decision-making between patients and their physicians, fostering patient engagement.

    Benefits of Integrating Carevala's AFib Program: The future of AFib management is bright with Carevala. Patients can look forward to early intervention, reduced stroke risk, improved quality of life, and efficient care delivery. Our solution is not just about managing AFib, it's about improving the lives of your patients. 

    • Early Intervention: Proactive screening and monitoring enable early detection, preventing complications and improving long-term outcomes.

    • Reduced Stroke Risk: Data-driven stroke risk assessment and medication adherence support help minimize the devastating consequences of AFib-related strokes.

    • Improved Quality of Life: By optimizing AFib management and addressing underlying conditions, patients experience better symptom control and enhanced overall well-being.

    • Efficient Care Delivery: RPM/CCM streamlines data collection and communication, relieving administrative burdens and allowing you to focus on clinical decision-making and patient care. With Carevala, you can spend more time on what matters most to patients, feeling efficient and less stressed.

    Partner with Carevala to elevate your AFib management strategy. Our comprehensive solution, leveraging the power of RPM/CCM, empowers you, the healthcare professional, to take control, optimize care, and improve outcomes. With Carevala, you can confidently manage AFib, knowing you have the best tools and support and feeling in control and confident.

    Partner with Carevala to elevate your AFib management strategy. Our comprehensive solution, leveraging the power of RPM/CCM, reassures you of improved outcomes and patient care. Contact Carevala to learn how to collaborate to transform AFib care for your patients today, feeling successful and fulfilled in your patient care.


  • The Power of Proactive Monitoring: Early Detection of Heart Failure Exacerbation with Carevala's RPM/CCM

    Remote patient monitoring (RPM) has proven to be an invaluable tool in the management of chronic conditions, especially for patients with a history of heart failure (HF). The ability to detect subtle changes in vital signs and symptoms before they escalate into significant events can significantly impact patient outcomes and reduce hospital readmissions. Carevala's recent case study demonstrates the power of our RPM/CCM platform in facilitating early identification and intervention for a patient with potential HF recurrence.

    Case Summary

    • Alert Trigger: A patient with a history of HF, enrolled in Carevala's RPM program, triggered an optional trending alert. This alert was not a standard warning but a unique feature of our platform that detected a gradual increase in blood pressure over four days despite remaining within the normal range. Concurrently, the patient reported mild ankle swelling.

    • Proactive Intervention: Following established protocols, a Carevala Coordinator, a key member of our dedicated care team, promptly scheduled a physician visit. The physician adjusted the patient's medication during the examination and recommended closer BP monitoring for the next three months.

    • Positive Outcome: With medication adjustment and increased surveillance, the patient experienced a decrease in weight, improved blood pressure, and resolution of ankle swelling, providing a profound sense of relief and reassurance. This suggests early identification and management of a potential HF exacerbation, reinforcing the effectiveness of our system.

    The Importance of Monitoring Subtle Changes

    This case highlights the critical role of continuous monitoring, even when individual readings appear normal. The gradual increase in blood pressure, coupled with the patient's report of ankle swelling, signaled a potential HF recurrence. Carevala's RPM platform enabled timely intervention, potentially preventing a more severe exacerbation and hospitalization.

    Carevala's Commitment to Proactive Care

    Our RPM/CCM platform is designed to empower patients and providers, fostering a strong sense of control and engagement to achieve optimal health outcomes. Key features include:

    • Continuous Monitoring: RPM devices track vital signs, weight, and other relevant metrics, providing real-time data for early detection of potential issues.

    • Personalized Alerts: Our platform generates tailored alerts based on individual patient parameters, ensuring timely interventions and avoiding alarm fatigue.

    • Dedicated Care Team: Our team of experienced clinicians and care coordinators provides ongoing support, education, and medication management, optimizing treatment plans and improving adherence.

    • Seamless Communication: Secure messaging and telehealth features facilitate communication between patients and providers, ensuring timely responses and personalized care.

    Conclusion

    This case demonstrates the power of Carevala's RPM/CCM platform in detecting subtle changes and preventing complications for patients with chronic conditions like heart failure. By enabling early intervention and personalized care, Carevala fosters a strong sense of partnership and collaboration, empowering patients and providers to work together to achieve better outcomes and improve quality of life.

    Contact Carevala to learn how to partner to leverage RPM/CCM for proactive, patient-centered care.

  • Put a Stop to Diabetic Foot Ulcers with Carevala

    Diabetic foot ulcers (DFUs) are a devastating complication of diabetes, causing immense suffering and imposing a significant burden on the healthcare system. The following statistics underscore the urgent and immediate need to address this issue:

    • Prevalence: 15-25% of people with diabetes will develop a DFU in their lifetime.

    • Costs: DFUs' financial burden is significant and places a heavy strain on the healthcare system. The average annual cost of care for Medicare patients is $11,710, and for privately insured patients, it is $16,883. Nationally, DFUs cost $9-13 billion annually, a staggering figure that underscores the financial strain and the need for cost-effective solutions.

    • Amputations: A staggering 85% of diabetes-related amputations, each costing around $70,000, begin as DFUs.

    • Recurrence and Mortality: DFUs have a high recurrence rate, and they significantly increase the risk of death by 2.5 times. This underscores the urgent need for effective prevention and management to reduce the risk of recurrence and mortality.

    The Urgent Need for Proactive Care

    These alarming statistics underscore the critical need for early intervention and comprehensive DFU prevention and management. Carevala's Zero Diabetic Foot Ulcer Program, built on the evidence-based recommendations of the International Working Group on the Diabetic Foot (IWGDF), offers a comprehensive and proactive solution to combat this crisis.

    Carevala's Multifaceted Approach

    • Identifying At-Risk Feet: Comprehensive screening for peripheral arterial disease, neuropathy, and foot deformities to identify high-risk patients.

    • Daily Inspection and Examination: Patients are empowered with education and tools to conduct daily foot inspections, track foot temperature, and report any concerns to their care team, thereby playing an active role in their health management.

    • Patient and Caregiver Education: Continuous, personalized education tailored to individual needs, cultural backgrounds, and health literacy levels.

    • Appropriate Footwear: Guidance on selecting and wearing proper footwear to prevent injury and promote foot health.

    • Addressing Risk Factors: Proactively managing blood sugar, blood pressure, and other modifiable risk factors to prevent ulcer formation and promote wound healing.

    Carevala's Technology: Empowering Patients and Providers

    • Remote Patient Monitoring: Continuous biometric monitoring of blood glucose, weight, activity levels, and foot temperature facilitates early detection of potential complications and proactive interventions.

    • Digital Unification: We seamlessly integrate digital tools with human connection, fostering engagement and supporting adherence to care plans.

    • Alert Coordinators: Our trained professionals provide 24/7 support, addressing patient concerns and escalating care when needed.

    • Advanced Diagnostics: Carevala utilizes innovative tools, such as Bluedrop Medical's Thermovisual Monitoring Device, for accurate and convenient foot temperature monitoring.

    Conclusion

    Carevala is committed to transforming diabetic foot care by prioritizing prevention, early detection, and personalized support. Our Zero Diabetic Foot Ulcer Program, grounded in evidence-based practices, empowers patients to participate actively in their health and achieve better outcomes. Don't just take our word for it; hear from our satisfied patients and healthcare partners about the positive impact of our program.

    Contact Carevala learn how we can partner with your healthcare facility to reduce the burden of diabetic foot ulcers and improve the lives of your patients. Together, we can make a difference.

  • Pharmacy Technicians: The Key Players in Enhancing Senior Medication Adherence

    The Challenge: Seniors often face challenges managing complex medication regimens, leading to poor adherence and increased health risks.

    Carevala's Solution: Our RPM/CCM platform, designed with user-friendliness in mind, recognizes the vital role of pharmacy technicians in improving medication adherence among seniors. It provides significant benefits for pharmacists and healthcare administrators, empowering pharmacy technicians to play a crucial part in this process. The platform streamlines operations, making it easy to use, and improves patient outcomes for pharmacists and healthcare administrators, leading to better health outcomes for senior patients.

    How Pharmacy Technicians Make a Difference:

    • Medication Reconciliation and Reviews: Ensuring accurate medication lists and identifying potential issues.

    • Patient Education and Counseling: Providing clear instructions and answering medication questions.

    • Medication Synchronization: Our platform simplifies medication schedules and coordinates refills, making the process not just convenient, but also efficient for seniors and healthcare providers, instilling a sense of reassurance and confidence in the platform's capabilities.

    • Adherence Monitoring and Support: Our platform utilizes a comprehensive range of tools, such as pill organizers and reminder apps, to monitor adherence. In addition, we provide follow-up calls to ensure that seniors follow their medication regimens. This thorough adherence monitoring and support approach significantly improves medication adherence among seniors.

    • Medication Therapy Management (MTM): Our pharmacy technicians collaborate with pharmacists to conduct comprehensive medication reviews, identify potential problems, and develop personalized care plans for each senior patient.

    Carevala's Technology Empowers Pharmacy Technicians:

    • Seamless EHR Integration: Real-time access to patient medication information for informed decision-making.

    • Telehealth Services: Remote medication counseling and adherence monitoring, especially beneficial for seniors with limited mobility.

    • Collaborative Care: Fostering communication and collaboration with the entire care team for a holistic approach.

    The Result: Our collective efforts, powered by Carevala's RPM/CCM platform, lead to improved medication adherence, reduced adverse events, and ultimately, better health outcomes for our senior patients, instilling a sense of optimism and motivation.

    Partner with Carevala:

    Contact us to learn how our platform can empower your pharmacy technicians and improve medication adherence in your senior patients.

  • The Importance of Standardized Testing of Hand and Finger Grip Dynamometry in Rheumatoid Arthritis Management: A Focus on Accurate Assessment and Carevala's RPM/CCM Approach

    Introduction

    Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes joint pain, stiffness, and swelling, leading to functional decline and disability. Muscle weakness is a common consequence of RA, often resulting from disuse atrophy and systemic inflammation. Handgrip strength, which is measured using a device called a dynamometer, is a simple and non-invasive measure of muscle function. It has emerged as a valuable tool for assessing disease activity, monitoring treatment response, and predicting long-term outcomes in RA patients. However, the lack of standardized protocols for handgrip dynamometry in RA can lead to inconsistent and unreliable results, hindering its clinical utility. This paper explores the importance of standardized handgrip dynamometry in RA management and discusses how Carevala's Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform can facilitate accurate and reliable assessment of muscle strength in this population, ultimately leading to improved patient outcomes.

    Integrating handgrip dynamometry testing, a valuable tool for assessing and monitoring muscle function in rheumatoid arthritis patients, with Carevala's RPM/CCM platform offers many benefits. It ensures accurate and reliable measurements, facilitates the development of personalized care plans, and empowers patients to manage their condition actively. This comprehensive approach not only promises better patient outcomes but also has the potential to revolutionize the approach to RA care, inspiring optimism in healthcare providers about the platform's capabilities. The platform is designed to be user-friendly, with comprehensive training and ongoing support, making it easy for healthcare providers to adopt and use effectively.

    The Role of Handgrip Strength in Rheumatoid Arthritis

    Handgrip strength plays a crucial role in RA assessment for several reasons:

    • Diagnostic Tool: Reduced grip strength can indicate early RA disease activity and functional impairment.

    • Prognostic Marker: Low grip strength has been associated with increased risk of disability, mortality, and cardiovascular events in RA patients.

    • Treatment Monitoring: Handgrip strength can be used to monitor the effectiveness of RA treatments, such as disease-modifying antirheumatic drugs (DMARDs) or physical therapy.

    • Assessment of Functional Status: Grip strength can provide insights into a patient's ability to perform daily activities and their overall quality of life.

    The Need for Standardized Protocols

    Challenges such as hand dominance, grip position, and test timing can significantly affect measurements, making it difficult to compare results across different studies and healthcare settings. The lack of standardized testing for handgrip dynamometry in RA can lead to inconsistent and unreliable results, underscoring the need for standardized protocols.

    Carevala's RPM/CCM Solution: Standardizing Handgrip Strength Assessment

    Carevala's RPM/CCM platform, with its unique features, offers a solution for implementing standardized handgrip strength assessment in RA patients:

    • Standardized protocols for handgrip dynamometry are a crucial component of Carevala's RPM/CCM platform. These protocols ensure consistency in measurement techniques, essential for obtaining reliable results. Using standardized protocols, healthcare providers can compare grip strength measurements across different patients over time, allowing for a more accurate assessment of disease progression and treatment effectiveness. This emphasis on reliability instills confidence in healthcare providers about the accuracy of the measurements, leading to more informed decision-making.

    • Remote Monitoring with Connected Dynamometers: RPM devices, such as Bluetooth-enabled handgrip dynamometers, can seamlessly integrate into the Carevala platform. This user-friendly feature allows patients to measure their grip strength at home and transmit data directly to their healthcare providers. This enables remote monitoring of muscle function and facilitates timely intervention, providing healthcare providers with a reliable and convenient tool for patient management. By empowering patients to participate actively in their care, this platform's simplicity and ease of use instill a sense of making a positive impact on their patients' lives in healthcare providers, empowering them with a reliable tool for patient management.

    • Personalized Care Plans: Carevala's CCM team, comprised of experienced healthcare professionals, works closely with RA patients to develop individualized care plans based on their grip strength measurements and other clinical data. These plans, which may incorporate exercise programs, physical therapy, or medication adjustments, are designed to improve muscle strength and function. The CCM team's expertise and dedication ensure that each patient receives a comprehensive and tailored care plan, enhancing the platform's effectiveness in improving patient outcomes.

    • With Carevala's RPM/CCM platform, patient education and engagement are prioritized. The platform provides patients with educational resources on the importance of muscle strength in RA management, empowering them to track their progress and actively participate in their care. This collaborative approach, which values the expertise and guidance of healthcare providers, is at the heart of Carevala's platform. By emphasizing this collaborative approach, the platform makes healthcare providers feel valued and integral to the patient's care, leading to better adherence to treatment plans and, ultimately, better health outcomes.

    Conclusion

    Contact Carevala today to learn more about how our platform can revolutionize your approach to rheumatoid arthritis care. Our team is ready to provide the necessary information and support to help you implement standardized handgrip dynamometry in your practice and improve your care for your RA patients. The implementation process typically involves a comprehensive training session for healthcare providers on using the platform and its various features, as well as ongoing support to ensure a smooth transition and optimal use of the platform in your practice. Our team is dedicated to helping you make the most of our platform and improve your patient care.

  • Enhancing Inhaler Use and Compliance in Asthma and COPD Management: The Role of Carevala's RPM/CCM Approach

    Introduction

    Proper inhaler technique and adherence to medication regimens are not just important; they are crucial for optimal disease management in patients with asthma and chronic obstructive pulmonary disease (COPD). However, research has consistently shown that a significant percentage of patients do not use their inhalers correctly, with up to 60% demonstrating improper technique. This widespread issue leads to decreased drug delivery, reduced effectiveness, and increased healthcare utilization, including emergency department (ED) visits. Improper inhaler use contributes to as much as 70% of the total healthcare costs for asthma and COPD management. This paper explores the potential of remote patient monitoring (RPM) in improving adherence, a promising development that could revolutionize respiratory care. It also discusses how Carevala's RPM/CCM platform can enhance respiratory care for patients with asthma and COPD, potentially reducing these costs.

    The Importance of Proper Inhaler Technique

    The angle at which a metered dose inhaler (MDI) is held during administration can significantly impact drug deposition in the lungs. For instance, if the MDI is held at an angle greater than 20°, the medication may be deposited on the tongue or the roof of the mouth, leading to reduced effectiveness. Similarly, if the MDI is not appropriately shaken before use, the medication may not be evenly distributed, leading to reduced effectiveness.

    Carevala's RPM/CCM Solution: Enhances Inhaler Use and Adherence

    Carevala's RPM and CCM programs offer a comprehensive and robust solution for improving inhaler technique and medication adherence, leaving no aspect of patient care unaddressed. This thorough approach is designed to reassure patients and healthcare providers, ensuring that every aspect of respiratory care is covered.

    • Remote Monitoring of Inhaler Use: Carevala's RPM devices, such as the CapMedic MDI Device, can track inhaler usage, including the date and time of use, shaking duration, orientation, and inhalation technique. This data, collected through the CapMedic MDI Device's built-in sensors, is securely stored and only accessible to authorized healthcare providers, ensuring patient privacy and data security.

    • Personalized Feedback and Education: Carevala's CCM team, using the RPM data, can provide detailed feedback to patients on their inhaler technique and adherence. This feedback can include specific areas for improvement, such as the angle at which the inhaler is held or the duration of shaking. In addition, educational resources on proper inhaler use, including instructional videos, interactive tutorials, and live demonstrations, can be delivered through the platform, empowering patients to improve their technique and achieve better outcomes.

    • Medication Reminders and Alerts: Carevala's platform can remind patients to take their medications as prescribed and alert healthcare providers of missed doses or suboptimal adherence. In the case of suboptimal adherence, the platform can notify the healthcare provider, who can then reach out to the patient to provide support and address any issues affecting adherence. This allows for timely intervention and support to improve medication adherence.

    • Integration with Spirometry: The CapMedic MDI Device also functions as a spirometer, a device that measures the volume of air inspired and expired by the lungs. This provides additional data on lung function, which can help healthcare providers monitor disease progression more accurately and adjust treatment plans more effectively, leading to better patient outcomes.

    Conclusion

    Improper inhaler use is a common barrier to effective asthma and COPD management. Carevala's RPM/CCM platform offers a comprehensive solution for improving inhaler technique and medication adherence with remote monitoring, personalized feedback, education, and support. By empowering patients with the tools and information they need, Carevala can help improve respiratory health outcomes and reduce the burden of these chronic conditions. This can give patients a sense of control over their health and instill confidence in their ability to manage their condition effectively.

    Contact Carevala today to learn more about how our platform can revolutionize your approach to respiratory care and improve patient outcomes.

  • The Future of Medical Care: Redefining How We Monitor & Improve Patient Outcomes with Advanced Digital Stethoscope Technology

    Eko's groundbreaking ECG + digital stethoscope technology, designed with unparalleled user-friendliness, is a game-changer in the diagnosis and management of cardiac and pulmonary diseases. The unique ability to remotely monitor heart and lung sounds with unmatched accuracy enables proactive interventions and early detection of complications, empowering you, the healthcare professional, to confidently manage your patients' conditions and improve their outcomes.

    Key Takeaways

    • Enhanced Remote Consultations: Eko's technology empowers physicians and nurses to conduct comprehensive cardiac and pulmonary assessments remotely, promoting access to care and reducing the need for in-person visits.

    • AI-Powered Diagnosis: The Eko DUO ECG + Digital Stethoscope combines artificial intelligence (AI) analysis with advanced auscultation and ECG capabilities, improving diagnostic accuracy and enabling timely intervention.

    • Versatile Applications: Eko's technology is not confined to a single specialty. It has extensive applications across various medical fields, including primary care, cardiology, and pulmonology. This versatility facilitates remote screening and monitoring for multiple conditions, making it an indispensable tool for healthcare professionals.

    • Proactive Care: The early detection of abnormal heart or lung sounds with Eko's technology allows for proactive management and intervention, potentially preventing exacerbations, hospitalizations, and readmissions.

    • Seamless EHR Integration: The Eko DUO's data is seamlessly integrated into the patient's electronic medical record (EMR), ensuring continuity of care and informed decision-making and giving you peace of mind about the patient's journey.

    Carevala: Empowering Providers and Patients with Eko DUO

    Carevala has added the Eko DUO ECG + Digital Stethoscope to its RPM devices, further expanding our commitment to providing comprehensive, patient-centered care. This integration empowers providers to:

    • Screen for Atrial Fibrillation (AFib) and Heart Murmurs: The Eko DUO allows for remote detection of irregular heart rhythms and murmurs, facilitating early diagnosis and timely intervention to reduce the risk of complications.

    • Monitor Lung Sounds in COPD and Asthma: The digital stethoscope enables the remote assessment of lung sounds, helping providers identify signs of exacerbation and adjust treatment plans accordingly.

    • Prevent Hospitalizations and Readmissions: The Eko DUO can help reduce the need for hospitalizations and emergency room visits by providing proactive monitoring and early detection of complications.

    • Improve Patient Engagement: Remote monitoring and telehealth consultations empower patients to participate actively in their care, fostering a sense of ownership over their health.

    Benefits of Integrating Carevala with Eko DUO

    • Improved Patient Outcomes: Early detection, proactive intervention, and personalized care plans can improve the outcomes and quality of life for patients with cardiovascular and pulmonary conditions.

    • Enhanced Care Coordination: Seamless data integration and communication tools facilitate provider collaboration, ensuring comprehensive and coordinated care.

    • Cost-Effective Solution: Using remote monitoring, Eko's technology can significantly reduce healthcare costs by preventing complications and hospitalizations. This cost-effective approach is a win-win for healthcare providers and patients, making it a compelling choice for any healthcare practice.

    Call to Action

    You're not alone with Eko's advanced digital stethoscope technology and Carevala's RPM/CCM platform. We offer comprehensive support and training to help you leverage these innovative tools for a proactive, patient-centered approach to chronic disease management.

    Contact Carevala to learn how to partner to leverage RPM/CCM and the Eko DUO for a proactive, patient-centered approach to chronic disease management.

  • The Importance of Diabetic Retinopathy Screening for Medical Professionals

    Diabetic retinopathy (DR) is a pressing global health issue, leading to blindness in millions of people with diabetes. The urgency of early detection and timely intervention cannot be overstated, yet many individuals with diabetes are not being screened or treated. This white paper underscores the critical importance of DR screening, introduces innovative solutions like the AEYE Diagnostic Screening method, and underscores how Carevala's remote patient monitoring (RPM) and chronic care management (CCM) can bolster comprehensive diabetes and eye health management.

    The Growing Burden of Diabetic Retinopathy

    • Urgent Need for Action: DR affects a significant portion of the diabetic population, with rates increasing rapidly in recent years, particularly among younger adults and certain racial/ethnic groups. This growing burden of DR calls for immediate and concerted efforts to address the issue.

    • Silent Progression: DR often progresses without noticeable symptoms until significant vision loss makes early detection crucial. This silent progression underscores the need for proactive screening.

    • Irreversible Consequences: Untreated DR can lead to blindness, impacting quality of life and increasing the risk of other complications. The irreversible nature of these consequences should underscore the gravity of the situation.

    The Importance of Screening

    Regular eye exams and screening for DR are essential for timely diagnosis and intervention. Key benefits include:

    • Early Detection: Identifying DR in its early stages allows prompt treatment to prevent or slow vision loss.

    • Improved Outcomes: Timely intervention with laser therapy or other treatments can preserve vision and significantly improve long-term outcomes. This potential for better patient outcomes should motivate medical professionals to prioritize DR screening.

    • Cost-Effectiveness: Early detection and treatment of DR save patients from the emotional and physical toll of vision loss and reduce the need for costly interventions and long-term care. This cost-effectiveness should appeal to the financial interests of medical professionals.

    Innovative Screening Solutions: AEYE Diagnostic Screening

    The AEYE-DS system leverages FDA-cleared AI technology to simplify and increase access to DR screening:

    • In-Office Screening: AEYE-DS enables annual DR screenings in primary care settings using an automated retinal camera, eliminating the need for specialist referrals.

    • Ease of Use: Any trained healthcare staff member can perform the simple procedure.

    • Reimbursement: Covered by Medicare and most insurance plans using CPT code 92229.

    Beyond the Eye: The Interconnectedness of DR and Other Chronic Conditions

    • Cardiovascular Disease (CVD): Individuals with DR have a higher risk of subclinical and overt CVD, including heart failure and lower extremity arterial disease (LEAD).

    • Diabetic Foot Ulcers (DFUs): DR is associated with an increased risk of DFUs and lower limb amputations, highlighting the need for comprehensive diabetes management.

    Carevala's Approach

    Carevala's RPM/CCM platform complements screening efforts and enhances diabetes management:

    • Risk Stratification: We identify high-risk patients for DR based on diabetes type, duration, HbA1c levels, and other factors.

    • Screening Facilitation: We schedule and coordinate annual or more frequent AEYE-DS screenings for eligible patients.

    • Remote Monitoring: RPM devices track blood glucose, blood pressure, and other metrics, providing data-driven insights into overall health and potential complications.

    • Personalized Care Plans: CCM professionals work with providers to develop tailored plans for diabetes management, eye health, and cardiovascular risk reduction.

    Call to Action

    By prioritizing DR screening and adopting innovative solutions like AEYE-DS, medical professionals can significantly reduce vision loss and improve the quality of life for individuals with diabetes. Carevala's RPM/CCM platform enhances these efforts by providing comprehensive monitoring, personalized support, and data-driven insights for optimal diabetes management. Your role in this process is crucial, and your efforts can make a significant difference in the lives of your patients.

    Contact Carevala to learn how to partner to empower your patients and improve outcomes.

  • Transforming Cancer Care with Remote Monitoring and Real-time Symptom Management

    Cancer patients undergoing chemotherapy face a challenging journey, often burdened by treatment side effects and the risk of complications. Carevala's Chemotherapy Connect program stands out with its unique combination of advanced remote patient monitoring (RPM) technology and proactive chronic care management (CCM). This patient-centric approach, in partnership with healthcare providers, significantly improves patient outcomes, reduces hospitalizations, and enhances the overall cancer care experience.

    Key Takeaways

    • Patient-reported outcomes (PROs) as a Cornerstone: Research demonstrates a strong link between PROs and essential indicators of patient well-being, such as performance status, treatment adherence, and symptom severity. Chemotherapy Connect facilitates the collection and analysis of PROs, empowering providers with the necessary data to make informed, personalized treatment decisions.

    • Proactive Management for Optimal Outcomes: Cancer patients are at risk for a variety of treatment-related complications. Carevala's real-time monitoring of vital signs and symptoms enables proactive interventions, potentially preventing costly and disruptive emergency room visits and hospitalizations. This cost-effective approach provides healthcare administrators with peace of mind, knowing that their resources are being used efficiently.

    • 24/7 Support: The Memorial Symptom Assessment Scale (MSAS) and 24/7 monitoring by our Alert Coordinators play a crucial role in providing continuous patient support. This comprehensive care ensures timely interventions and peace of mind for patients, contributing significantly to their well-being and instilling confidence in healthcare providers, who can rest assured that their patients are always supported.

    • Early Fever Detection: Fever is a critical warning sign in oncology patients. Carevala's continuous temperature monitoring is a crucial feature of the Chemotherapy Connect program. It enables rapid detection and response, which is vital in preventing severe health events. This focus on preventive care ensures patients feel secure and protected, instilling a sense of safety in healthcare providers.

    Ideal Applications

    Chemotherapy Connect is an invaluable tool for various oncology specialties and can be seamlessly integrated into existing healthcare systems, ensuring minimal disruption and maximum compatibility. This seamless integration provides healthcare providers with a sense of ease and comfort.

    • Hematology/Oncology: Monitoring treatment response and managing side effects for various cancers.

    • Bone Marrow Transplant: This procedure supports patients during the vulnerable post-transplant period and enables early detection of complications like infections or graft-versus-host disease.

    • Acute Leukemia: Monitoring for febrile neutropenia and other complications associated with intensive chemotherapy regimens.

    • Palliative Care: Improving symptom management and quality of life for patients with advanced cancer.

    • Gynecologic Oncology: Managing side effects of chemotherapy and radiation therapy in gynecologic cancers.

    • Cardio-oncology: Addressing the unique needs of cancer and cardiovascular disease patients.

    Benefits of Chemotherapy Connect

    • Improved Patient Outcomes: Proactive monitoring and timely intervention can reduce complications and hospitalizations and improve overall health outcomes.

    • Enhanced Patient Experience: Real-time support, personalized interventions, and patient education empower individuals throughout their cancer journey.

    • Reduced Healthcare Costs: Chemotherapy Connect can significantly lower healthcare costs by preventing complications and reducing hospitalizations.

    • Streamlined Workflows: Remote monitoring and centralized data management enhance care coordination and reduce the administrative burden on providers.

    Call to Action

    Carevala's Chemotherapy Connect offers a transformative solution for cancer care delivery, empowering patients and providers with the tools and insights needed to achieve optimal outcomes. This empowerment instills a sense of control and confidence in the cancer care journey, making patients and providers feel more in control and confident.

    Discover the Power of Chemotherapy Connect. Contact Carevala to learn how we can partner to revolutionize cancer care.

  • Upgrade Your Heart Health Monitoring: The KardiaMobile 6L Advantage.

    As healthcare providers, we recognize the crucial role of continuous, precise heart health monitoring, particularly for those at risk of or living with cardiovascular conditions. Carevala is excited to offer a complimentary upgrade to the KardiaMobile 6L for existing KardiaMobile users. Combined with our Remote Patient Monitoring (RPM) program, this advanced device can significantly improve your heart health management, empowering you to take charge of your cardiovascular well-being.

    Why Upgrade to the KardiaMobile 6L?

    1. Enhanced Diagnostic Capabilities: The KardiaMobile 6L, a six-lead ECG device, offers a more comprehensive view of your heart's electrical activity than the single-lead KardiaMobile. This allows for the detection of a broader range of heart conditions, including Atrial Fibrillation (AFib), Premature Ventricular Contractions (PVCs), Supraventricular Extrasystoles (SVEs), and more, with enhanced accuracy.

    2. Increased Ease of Use: The KardiaMobile 6L offers greater flexibility with its Bluetooth connectivity. You can now take readings without any hearing aid interference or susceptibility to electrical noise, ensuring a convenient and reliable monitoring experience.

    3. Physician-Reviewed Results: All abnormal EKGs recorded with the KardiaMobile 6L are reviewed by a qualified physician who provides expert insights and a deeper understanding of your heart health. The thorough review process ensures that you receive accurate and reliable information about your heart health.

    4. 24/7 Monitoring with Alerts: Carevala's RPM program continuously monitors your heart health with real-time alerts for any concerning changes. This proactive approach ensures timely intervention and can help prevent complications. The RPM program also provides personalized health insights, connects you with healthcare professionals, and offers educational resources to empower you in managing your heart health.

    5. Seamless Data Integration: Abnormal EKGs are automatically transmitted to your doctor's Electronic Medical Record (EMR), ensuring your physician stays informed and can adjust your care plan as needed.

    Carevala RPM: Comprehensive Care

    Our RPM program, paired with the KardiaMobile 6L, goes beyond just EKG monitoring:

    • HIPAA-Compliant Data Storage: Your data is securely stored and protected, ensuring privacy.

    • No Membership or Device Replacement Costs: We had a hassle-free experience with no hidden fees or unexpected expenses.

    • Medication Tracking: Our platform helps you monitor your medications, reducing the risk of missed doses or adverse events.

    • Additional Monitoring Devices Available: We offer a variety of other RPM devices to track blood pressure, blood glucose, weight, and other vital signs.

    • Additional Programs: In addition to our RPM program, Carevala provides access to nutritional consultations, cognitive testing, and kidney disease screening to support your overall health and well-being. These programs complement our RPM program and comprehensively support your health journey.

    • Comparison Chart

    Feature

    KardiaMobile (Original)

    KardiaMobile 6L

    Heart Conditions Detected

    AFib, Tachycardia, Bradycardia

    AFib, PVCs, SVE, Wide QRS, and more

    Connectivity

    Sound-based

    Bluetooth

    Physician Review

    No

    Yes (with Carevala RPM)

    Monitoring & Alerts

    No

    Yes (with Carevala RPM/CCM)

    Membership Required for Advanced Features

    Yes (KardiaCare)

    No (with Carevala RPM/CCM)

    The Carevala Advantage

    We are committed to empowering patients and providers with the tools and support they need to achieve optimal heart health. Carevala's RPM program and the KardiaMobile 6L offer a proactive, data-driven approach to cardiovascular care.

    Contact Carevala to learn how we can support your heart health journey and help you achieve better outcomes.

  • Transforming Senior Diabetes Care with Automatic Insulin Delivery (AID) Systems: Revolutionizing Diabetes Management for Older Adults

    Automatic Insulin Delivery (AID) systems, also known as artificial pancreas devices, are revolutionizing diabetes care. These systems integrate continuous glucose monitoring (CGM) with insulin pumps to automate insulin delivery, responding to real-time fluctuations in glucose levels. For seniors managing Type 1 and Type 2 diabetes (T1D and T2D), AID systems offer life-changing benefits, enhancing glycemic control, preventing severe complications, and restoring independence (Bergenstal et al., 2021).

    Type 1 Diabetes (T1D): AID Systems Offer Unmatched Stability and Safety

    Clinical Outcomes: Protecting Seniors from Life-Threatening Falls

    Older adults with T1D face a heightened risk of severe hypoglycemia, which can result in cognitive decline, dangerous falls, and hospitalization. A study in Diabetes Technology & Therapeutics found that AID systems reduce hypoglycemia episodes by up to 50%, significantly improving quality of life and safety (Brown et al., 2022). Seniors who once struggled with unpredictable glucose levels now experience newfound confidence and stability.

    Cost Savings: Slashing Healthcare Costs and Preventing Emergencies

    The economic benefits of AID adoption are substantial. The NHS in England projects that the widespread use of AID systems could save millions of pounds annually by preventing costly complications, such as strokes and hospitalizations due to hypoglycemia (NHS England, 2023). This technology not only preserves health but also alleviates financial strain on healthcare systems and families.

    Type 2 Diabetes (T2D): A Paradigm Shift in Treatment

    Clinical Outcomes: Reducing Risks, Enhancing Longevity

    For seniors with insulin-treated type 2 diabetes, maintaining stable blood glucose levels is crucial for preventing cardiovascular disease, neuropathy, and kidney failure. A randomized controlled trial published in The New England Journal of Medicine demonstrated that AID systems reduced HbA1c levels and hyperglycemia without increasing the risk of hypoglycemia, thereby empowering seniors to lead healthier, more active lives (Peters et al., 2021).

    Cost Savings: Long-Term Financial Relief

    Although specific cost analyses for T2D patients using AID systems are still emerging, research indicates that even a 1% reduction in HbA1c levels can result in a 10% decrease in diabetes-related healthcare expenses (Huang et al., 2020). By preventing long-term complications, AID systems promise significant savings for both patients and healthcare providers.

    Economic and Healthcare Advantages of AID Systems

    1. Preventing Hospitalizations and Emergency Room Visits

    • AID systems drastically lower the likelihood of severe hypoglycemia and diabetic ketoacidosis (DKA), both of which are major drivers of emergency care costs (Weinstock et al., 2021).

    • The cost of a single hospitalization for DKA can range from $10,000 to $30,000 (American Diabetes Association, 2023). AID technology helps eliminate these preventable expenses.

    2. Long-Term Savings Through Complication Prevention

    • AID systems optimize blood glucose control, reducing the risk of costly complications such as neuropathy, kidney disease, and heart disease—conditions that can require tens of thousands of dollars in medical interventions (Nathan et al., 2022).

    • A study in Diabetes Care estimated that improved glycemic control can save patients $3,000 to $6,000 annually by reducing complications (Miller et al., 2020).

    3. A National Economic Game Changer

    • By reducing diabetes-related hospitalizations, AID systems could save $5,000–$10,000 per patient annually, depending on disease severity and prior management strategies (Sherr et al., 2021).

    • The widespread adoption of AID systems in T1D could save the U.S. healthcare system billions of dollars over time, making it a financially sound investment (Hirsch et al., 2023).

    AID Systems: A Lifeline for Seniors with Diabetes

    For older adults, the benefits of AID systems extend far beyond blood sugar control:

    • Eliminating Dangerous Lows: Seniors with diabetes often struggle with severe hypoglycemia, leading to life-threatening situations. AID systems provide life-saving glucose stability, offering a sense of security and peace of mind to both seniors and their caregivers (Munshi et al., 2022).

    • Regaining Independence: Managing diabetes manually can become overwhelming with age. AID technology reduces the need for constant monitoring, allowing seniors to enjoy their daily lives with confidence and caregivers to feel less burdened (McGill et al., 2021).

    • Preserving Cognitive Function: Consistent glucose control has been linked to a reduced risk of diabetes-related dementia. AID systems contribute to long-term cognitive health and overall well-being, instilling a sense of optimism about the future in seniors and caregivers (Biessels & Despa, 2018).

    Conclusion: The Future of Diabetes Care is Here

    AID systems are not just an upgrade to traditional diabetes management—they are a transformative technology that empowers seniors with T1D and insulin-dependent T2D. By preventing dangerous complications, enhancing quality of life, and driving substantial healthcare savings, AID systems should be a standard of care for all eligible patients. The future of diabetes management is here, and for seniors, it means longer, healthier, and more independent lives.

    References

    • American Diabetes Association. (2023). The Cost of Diabetes Care in the U.S.

    • Bergenstal, R. M., et al. (2021). Advancements in AID Systems for Diabetes Management.

    • Biessels, G. J., & Despa, F. (2018). Diabetes and Cognitive Decline. Lancet Neurology.

    • Brown, S. A., et al. (2022). AID Systems and Hypoglycemia Reduction in Older Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics.

    • Hirsch, I. B., et al. (2023). The Economic Impact of Widespread Adoption of AID.

    • Huang, E. S., et al. (2020). The Relationship Between HbA1c Reduction and Healthcare Costs.

    • McGill, D. E., et al. (2021). Diabetes Management in Older Adults.

    • Miller, K. M., et al. (2020). Glycemic Control and Cost Savings in Diabetes Care. Diabetes Care.

    • Munshi, M. N., et al. (2022). Managing Diabetes in the Elderly: Benefits of AID Systems.

    • Nathan, D. M., et al. (2022). Long-Term Complications of Diabetes and Their Costs.

    • NHS England. (2023). The Future of Diabetes Care: Cost Savings Through AID Systems.

    • Peters, A. L., et al. (2021). AID Systems in Insulin-Treated Type 2 Diabetes: Clinical Trial Results. The New England Journal of Medicine.

    • Sherr, J. L., et al. (2021). Healthcare Cost Savings with AID Systems.

    • Weinstock, R. S., et al. (2021). Reduction of DKA and Emergency Visits with AID Systems.

  • "Don't Fall Through the Cracks": Proactive Fall Prevention for Older Adults with Carevala's RPM/CCM

    Falls are not just accidents; they are a significant threat to the health and independence of older adults. They lead to injuries, hospitalizations, and decreased quality of life. Shockingly, one-third of seniors experience a fall each year, costing the U.S. healthcare system a staggering $50 billion annually. The good news is that many falls are preventable. Carevala's RPM/CCM platform offers a proactive, evidence-based solution to address fall risk and improve patient outcomes.

    The High Cost of Falls in Older Adults

    Falls can have devastating consequences for seniors:

    • Injuries: Fractures, head injuries, and soft tissue trauma are common, leading to pain, disability, and reduced independence.

    • Hospitalizations: Falls often require emergency department visits and hospital admissions, further complicating existing health conditions and increasing healthcare costs.

    • Psychological Impact: The fear of falling can lead to social isolation, depression, and decreased physical activity, creating a downward spiral for overall well-being.

    Carevala's Comprehensive Fall Prevention Program

    Carevala's Fall Prevention Program is not just another solution. It's a comprehensive approach that leverages RPM/CCM technology and personalized care to proactively identify and manage fall risk.

    • Risk Assessment: We conduct comprehensive assessments to identify high-risk patients using validated tools like the CDC's STEADI algorithm and the American Geriatrics Society's recommendations.

    • Kinesis QTUG™ Technology: Our platform integrates the Kinesis QTUG™ assessment tool, a portable and accurate measure of mobility and fall risk that goes beyond traditional methods.

    • Personalized Treatment Plans: Our care team collaborates with providers to develop tailored care plans incorporating interventions like physical therapy, medication adjustments, home safety modifications, and assistive devices.

    • Ongoing Monitoring: Regular reassessment and remote monitoring of patient progress allow for timely adjustments to care plans and optimization of interventions.

    Benefits for Healthcare Providers

    Carevala's Fall Prevention Program empowers providers to:

    • Prevent Falls and Improve Outcomes: Reduce the risk of falls, fractures, and associated complications, leading to better patient outcomes and quality of life.

    • Utilize Data-Driven Care: Objective assessment tools inform treatment decisions and track the effectiveness of interventions.

    • Take a Holistic Approach: Our RPM/CCM platform addresses overall health and wellness, including medication management, nutrition, and exercise, to support fall prevention efforts.

    Why Choose Carevala?

    • End-to-end Solution: We handle the entire process, from risk identification to ongoing management, ensuring comprehensive care and making you feel you are providing the best care possible.

    • Validated Methodology: Our program uses proven tools and protocols, ensuring reliable results and informed decision-making.

    • Patient Engagement: We empower patients to actively participate in their care, promoting self-management and adherence to fall prevention strategies. This makes you feel that you are making a positive impact on your patients' lives.

    Call to Action

    Falls are a preventable tragedy. Partner with Carevala to leverage the power of RPM/CCM and proactive care to protect your senior patients and significantly reduce the burden of falls, providing you with a sense of reassurance and less stress.

    Contact Carevala to learn how our Fall Prevention Program can enhance your practice and improve the lives of your patients. 

  • Nutritional Intervention Therapy (NIT): Empowering Patients to Improve Health Through Food

    Healthcare professionals, including registered dietitians and nutritionists, are the cornerstone of Nutritional Intervention Therapy (NIT). Their personalized nutrition counseling is a potent tool for addressing the root causes of chronic diseases and empowering patients to make sustainable lifestyle changes that promote long-term well-being. Carevala's RPM/CCM platform can enhance the delivery and effectiveness of NIT, supporting patients in their journey toward optimal health.

    Critical Benefits of Nutritional Intervention Therapy

    NIT offers a multifaceted approach to improving health outcomes through personalized nutrition counseling:

    • Addresses Root Causes: NIT helps patients understand the connection between food choices and health conditions, empowering them to make informed decisions and take ownership of their well-being.

    • Manages Chronic Conditions: By providing tailored guidance on diet and lifestyle modifications, NIT can help patients manage symptoms, slow disease progression, and potentially reduce their reliance on medications.

    • Supports Overall Well-being: A healthy diet improves energy levels, mood, and overall quality of life, fostering a sense of empowerment and control over one's health.

    Carevala: Your Partner in Nutritional Wellness

    Carevala's RPM/CCM platform integrates seamlessly with NIT, providing comprehensive and unwavering support for patients seeking to improve their health through dietary changes:

    • One-on-One Consultations: Our registered dietitians and nutritionists offer personalized assessments, education on the relationship between diet and health conditions, and ongoing support, empowering patients to make sustainable changes.

    • Meal Planning Assistance: We provide optional meal plans that align with NIT principles and cater to individual dietary needs and preferences.

    • Remote Monitoring: RPM devices track relevant health metrics, such as blood pressure, blood glucose, and weight, allowing for continuous monitoring of the impact of dietary interventions and providing data-driven insights for personalized care plans.

    • Ongoing Support and Feedback: Our care team provides regular check-ins, motivation, and adjustments to care plans as needed, ensuring patients stay on track and achieve their health goals.

    The Benefits of NIT for Patients NIT offers many benefits, including improved health outcomes, increased energy and vitality, and a sense of empowerment and confidence in managing their health through healthy eating.

    • Improved Health Outcomes: By addressing the root causes of chronic conditions, NIT can lead to reduced complications, better blood sugar control, improved blood pressure, and a decreased risk of hospitalization.

    • Increased Energy and Vitality: Nutritious, whole foods provide the body and mind with the fuel they need for optimal function, leading to increased energy and vitality.

    • Empowerment and Confidence: Through healthy eating, patients gain the knowledge and skills to manage their health, fostering a sense of empowerment and control over their well-being.

    Call to Action

    Incorporating Nutritional Intervention Therapy into chronic disease management can significantly improve patient outcomes and quality of life. Carevala's RPM/CCM platform enhances the delivery of NIT, providing personalized support, continuous monitoring, and data-driven insights to empower patients and providers to work together toward achieving optimal health.

    Contact Carevala to learn how we can partner to leverage RPM/CCM for a holistic nutrition and chronic disease management approach.

  • Regaining Control After Ostomy Surgery: The Critical Role of Specialized Care and Remote Patient Monitoring

    Living with an ostomy can be a challenging and complex journey, involving not only physical adjustments but also emotional and psychological impacts. Despite the life-saving benefits of ostomy surgery, patients often face inadequate support after hospital discharge, increasing the risk of complications, emergency room visits, and readmissions. Carevala's Specialized Ostomy Aftercare Program (SOAP), integrating remote patient monitoring (RPM) and chronic care management (CCM), is designed to bridge this gap, providing patients with the comprehensive support they need to achieve optimal outcomes and regain control of their lives.

    Key Challenges and Risks for Ostomy Patients

    • High Readmission Rates: 38% of ostomy patients experience readmissions or ER visits within 90 days, often due to preventable complications like dehydration and skin issues.

    • Parastomal Hernias: These hernias are a common complication, leading to discomfort and digestive problems.

    • Nutritional Imbalance: Changes in the digestive tract after surgery require dietary adjustments and careful medication management to ensure adequate nutrition and prevent complications like renal failure.

    • Emotional and Psychological Impact: Adjusting to an ostomy can lead to anxiety, depression, and a sense of loss of control.

    How Carevala's SOAP Uniquely Addresses These Challenges

    Carevala's SOAP offers a patient-centered, multidisciplinary approach to ostomy care:

    • Expert Ostomy Care: Our team of certified Wound Ostomy Nurses (WOCNs) provides specialized guidance on ostomy management, skincare, and product selection. We also recognize the crucial role of caregivers in the patient's journey and provide them with the necessary training and support.

    • Proactive Monitoring: RPM devices enable continuous vital signs and fluid balance monitoring, facilitating early detection of complications like dehydration or infection.

    • Personalized Nutrition Counseling: Our registered dietitians provide tailored dietary plans to ensure adequate nutrition and manage medication interactions.

    • Telemedicine and Continuous Support: Virtual consultations with our care team offer convenient access to expert advice and support, reducing the need for in-person visits and providing relief and support. This means you can get the help you need without the hassle of travel or waiting rooms.

    • Seamless Supply Access: Carevala ensures uninterrupted access to essential ostomy supplies, eliminating anxiety and promoting adherence to care plans.

    Discover the benefits of Carevala’s SOAP.

    • Proactive Care: Reducing Hospitalizations and ER Visits

    • Improved Patient Outcomes: Comprehensive care and support lead to better wound healing, optimized nutrition, and enhanced quality of life.

    • Patient Empowerment: Our platform empowers patients to actively manage their ostomy actively, fostering a sense of independence and confidence.

    • Cost-Effective Care: Carevala's SOAP can lower healthcare costs by preventing complications and reducing hospitalizations, providing a secure and financially savvy solution.

    Call to Action

    Living with an ostomy can be challenging, but it doesn't have to be overwhelming. Carevala's Specialized Ostomy Aftercare Program offers a comprehensive solution for navigating the complexities of post-surgery care, providing a comforting and reassuring support system that empowers patients to thrive and regain control of their lives.

    Contact Carevala to learn how we can partner to provide the specialized ostomy care your patients deserve. Don't wait; take the first step towards better ostomy care today.

  • Achieving Optimal Blood Pressure Control: The Critical Role of Accurate Monitoring and Carevala's RPM/CCM Solution

    Accurate blood pressure (BP) measurement is paramount in the diagnosis and management of hypertension, a significant risk factor for cardiovascular disease and stroke. Unfortunately, inaccurate readings are common, leading to misdiagnosis, inappropriate treatment decisions, and missed opportunities for intervention. Carevala's remote patient monitoring (RPM) and chronic care management (CCM) platform, which involves continuous monitoring of patient's health remotely and comprehensive management of chronic conditions, utilizes clinically validated blood pressure monitors and comprehensive patient support to ensure precise readings and improve outcomes. This is achieved through [brief explanation of how the platform works].

    Why Accurate BP Monitoring Matters

    Reliable BP readings are crucial for the following:

    • Accurate Diagnosis: Inaccurate measurements can lead to misdiagnosis, either overestimating or underestimating the presence or severity of hypertension, which can have profound implications for patient health and safety. This underlines the critical need for reliable BP readings and the urgency to address this issue.

    • Effective Treatment: Accurate BP data is crucial for personalized care plans and medication adjustments. Unreliable readings can lead to undertreatment or overtreatment, significantly impacting patient outcomes and safety. Your role in providing accurate readings is crucial for the best patient outcomes and is a testament to your professional commitment.

    • Preventing Complications: Uncontrolled hypertension increases the risk of heart attack, stroke, kidney failure, and other serious complications. Precise BP monitoring is critical to identifying at-risk patients and facilitating timely intervention.

    Choosing the Right Blood Pressure Monitor

    Not all BP monitors are created equal. Prioritizing devices undergoing rigorous testing and validation is essential to ensure clinical accuracy. Carevala recommends the following resources for identifying validated monitors:

    • US Blood Pressure Validated Device Listing (VDL™): This resource, maintained by the American Medical Association, lists devices that have passed strict accuracy standards.

    • STRIDE BP: This international initiative uses established protocols to validate blood pressure monitors, ensuring reliability and comparability of readings.

    Carevala: Your Trusted Partner in Accurate BP Monitoring. With Carevala, you can be confident in the accuracy of your BP readings and the support you provide to your patients. We are here to support you in your mission to provide the best care.

    Carevala's RPM/CCM platform prioritizes accuracy and patient support:

    Benefits of Choosing Carevala for Hypertension Management

    • Data You Can Trust: Accurate BP readings are the foundation of effective hypertension management. Carevala's use of validated devices and patient education ensures reliable data.

    • Holistic Approach: We go beyond BP monitoring to address the root causes of hypertension through lifestyle modifications, medication adherence, and comprehensive support.

    • Focus on Outcomes: Carevala is committed to helping patients achieve and maintain healthy blood pressure levels, reducing the risk of complications, and improving long-term health outcomes.

    • Validated Devices Only: We exclusively use blood pressure monitors from reputable manufacturers listed on the VDL or STRIDE BP.

    • Patient Education: Our dedicated care team, consisting of experienced nurses and healthcare professionals, provides thorough training on proper BP measurement techniques, ensuring patients obtain reliable readings at home. They also offer guidance on lifestyle modifications and medication adherence.

    • Clinical Expertise: Our trained clinicians collect and actively review RPM data, allowing for the timely identification of trends and proactive interventions to optimize BP control rather than just reacting to changes.

    Call to Action

    Accurate blood pressure monitoring is essential for optimizing hypertension management and preventing complications. Carevala's RPM/CCM platform empowers providers with reliable data and personalized support to deliver practical, patient-centered care.

    Contact Carevala to learn more about how our RPM/CCM platform can support your hypertension management efforts and improve patient health and outcomes. We're here to answer any questions you may have and help you take the next step in optimizing your hypertension management practices.

  • Uncovering the Hidden Health Risks of Atrial Fibrillation and Cardiovascular Disease with Sleep Apnea Screening

    The Silent Threat of Obstructive Sleep Apnea (OSA)

    Obstructive Sleep Apnea (OSA) is not just prevalent; it's alarmingly so, yet often undiagnosed. Research suggests that up to 95% of OSA cases remain undetected, underscoring the urgent need for proactive screening and management. This is where Carevala's remote patient monitoring (RPM) and chronic care management (CCM) solutions can make a significant difference.

    The Connection Between OSA, AFib, and Cardiovascular Disease

    • Undiagnosed and Undertreated: Shockingly, the vast majority of OSA cases go undetected, hindering timely intervention and treatment. This underscores the urgent need for proactive screening and management.

    • OSA is a known risk factor for AFib, and the two conditions often coexist, significantly increasing cardiovascular risk.

    • Worsened Outcomes: Untreated OSA can contribute to the progression of heart failure, increase the risk of AFib recurrence after treatment, and negatively impact overall cardiovascular health.

    The Need for Convenient OSA Screening

    Early detection and diagnosis of OSA are crucial for mitigating its adverse effects on cardiovascular health. Carevala facilitates proactive screening through:

    • Standardized Screening Tools: We utilize validated questionnaires such as the Berlin Questionnaire, STOP-Bang, and NoSAS to identify high-risk individuals.

    • Home Sleep Testing: We offer convenient, at-home sleep apnea testing with devices like the WatchPAT™ ONE-M, eliminating the need for overnight stays in sleep labs.

    • Targeted Screening: We focus on high-risk groups, including patients with AFib, heart failure, hypertension, and stroke, where the prevalence of OSA is over 60%, ensuring efficient resource allocation.

    Carevala: Your Partner in OSA Diagnosis and Management

    Carevala's integrated RPM/CCM platform is not just a tool, but your comprehensive solution for effectively identifying and managing OSA and addressing its impact on AFib and cardiovascular disease. It's your partner in OSA diagnosis and management, providing the support and resources you need. At Carevala, we don't just scratch the surface. We offer a comprehensive sleep assessment that combines validated screening tools with advanced home sleep testing for accurate diagnosis and risk stratification. This thorough approach ensures no stone is left unturned in the quest for better health.

    • Integrated Care for AFib Patients: We address OSA as part of a holistic approach to care for patients with AFib, optimizing treatment plans and reducing the risk of recurrence.

    • Post-Ablation Monitoring: Our platform enables close monitoring for OSA recurrence after AFib ablation procedures, ensuring timely intervention to prevent relapse.

    • Multidisciplinary Approach: Carevala's CCM team addresses modifiable risk factors for OSA, including hypertension, weight management, and lifestyle modifications, collaborating with various specialists to provide comprehensive care.

    Benefits of Choosing Carevala

    • Improved Cardiovascular Outcomes: By addressing OSA, Carevala can help improve blood pressure control, reduce the progression of heart failure, and enhance overall cardiovascular health.

    • Better AFib Control: Effective OSA management can improve AFib treatment outcomes and lower the risk of recurrence.

    • Patient-Centered Care: Our convenient, at-home sleep testing options and personalized care plans empower patients and improve their overall experience.

    Call to Action

    OSA is a significant but often overlooked risk factor for cardiovascular disease and AFib. Carevala's RPM/CCM platform offers a comprehensive solution for proactive OSA screening and management, empowering patients and providers to work together to improve outcomes and achieve better heart health.

    Contact Carevala to learn how we can partner to leverage RPM/CCM for a holistic approach to cardiovascular care.

  • Unlocking the Secrets of Value-Based Care: How Carevala Drives Improved Outcomes and Financial Success

    The U.S. healthcare system is currently grappling with a pressing crisis of chronic disease prevalence and unsustainable costs. The transition to value-based care (VBC) models offers a promising solution, incentivizing healthcare providers, including physicians, nurses, and healthcare administrators, to focus on quality care and patient outcomes. Remote patient monitoring (RPM) and chronic care management (CCM) are powerful tools to help providers succeed in this new era. Carevala, a leading RPM/CCM provider, plays a crucial role in this transition, offering a comprehensive platform to empower patients and providers to deliver and receive better care.

    The Need for Value-Based Care

    The current fee-for-service model incentivizes volume over value and has contributed to a system focused on treating acute illnesses rather than preventing chronic conditions. VBC models aim to change this by:

    • Prioritizing Patient Health: Shifting the focus towards proactive management of chronic diseases and preventive care, leading to improved health outcomes and a better quality of life.

    • Improving Efficiency: Reducing unnecessary hospitalizations, emergency room visits, and readmissions through remote monitoring and proactive intervention.

    • Rewarding Quality: Aligning reimbursement with patient outcomes and satisfaction rather than the number of procedures performed.

    The Carevala Difference: Data-Driven, Personalized Care

    Carevala's RPM/CCM platform is not just another tool; it's a comprehensive solution meticulously designed to support value-based care initiatives:

    • Focus on High-Impact Conditions: We target chronic diseases like heart failure, COPD, CKD, asthma, and diabetes, where RPM/CCM has the potential to significantly reduce complications and improve outcomes, offering a ray of hope for better patient health.

    • Actionable Insights: Our platform collects and analyzes real-time patient data, translating it into actionable recommendations for providers and patients. These insights could include personalized medication adjustments, lifestyle changes, or early warning signs of potential health issues, empowering providers and patients with the information they need to make informed decisions about their health.

    • Personalized Patient Goals: We work with patients and providers to develop individualized care plans that address specific health needs and promote self-management.

    • Seamless Integration: Carevala's platform is thoughtfully designed to seamlessly integrate into existing workflows, ensuring minimal disruption and maximizing provider efficiency. This feature addresses concerns about the practicality of adopting new technology in a busy healthcare environment, making the transition to value-based care smoother and more manageable.

    Benefits for Healthcare Providers

    Partnering with Carevala offers numerous benefits for providers navigating the shift to value-based care:

    • Improved Clinical Outcomes: RPM/CCM can significantly improve outcomes for patients with chronic conditions, including reduced hospitalizations, lower complications, and enhanced quality of life.

    • Enhanced Patient Engagement: Carevala empowers patients with tools and resources for self-management, improving adherence to treatment plans and promoting a collaborative approach to care, thereby enhancing patient engagement and satisfaction.

    • Financial Success in VBC: Carevala helps providers succeed in value-based reimbursement models by demonstrating improved outcomes and reducing costs. Carevala is open to many payment models, including value-based care and capitation models. This flexibility allows providers to choose the model that best fits their practice and can lead to significant cost savings and improved financial performance.

    Call to Action

    Embrace the future of healthcare with Carevala's RPM/CCM platform. We are committed to partnering with providers to deliver proactive, patient-centered care that improves outcomes, reduces costs, and helps you thrive in the era of value-based reimbursement.

    Contact Carevala to learn how we can transform chronic disease care and support your transition to value-based care. Embrace the future of healthcare with Carevala's RPM/CCM platform. We are committed to partnering with providers to deliver proactive, patient-centered care that improves outcomes, reduces costs, and helps you thrive in the era of value-based reimbursement. Join us in this transformative journey today.

  • Carevala’s Technology-Driven Approach to Diabetes Management

    Older adults with type 1 diabetes face a heightened risk of hypoglycemia, which can lead to serious adverse events and complications. Automated insulin delivery (AID) systems have shown promise in mitigating this risk.

    Diabetes overtreatment, particularly in older adults (≥65 years) with type 2 diabetes, remains a significant clinical challenge. Defined traditionally as achieving HbA1c <7% with insulin or sulfonylureas, it often leads to increased risks of hypoglycemia and other complications. Recent research, including an ancillary study to the HYPOAGE trial published in Diabetes Care (PMID: 38080894), highlights the limitations of HbA1c-based definitions and advocates for a more nuanced, technology-driven approach. 

    Carevala's RPM and CCM programs offer a comprehensive solution to address the limitations of traditional overtreatment definitions and improve diabetes management in older adults:

    • Continuous Glucose Monitoring (CGM) Integration:

      • Carevala facilitates using CGM devices, providing real-time glucose data to identify and prevent hypoglycemia.

      • CGM data allows for personalized adjustments to medication and lifestyle interventions.

    • Personalized Care Plans:

      • Carevala develops individualized care plans based on CGM data, medication history, comorbidities, and patient preferences.

      • Care plans focus on minimizing hypoglycemia risk while maintaining optimal glycemic control.

    • Remote Monitoring and Intervention:

      • Carevala's RPM technology enables remote monitoring of glucose trends, medication adherence, and symptom reporting.

      • The CCM team provides timely interventions to prevent or manage hypoglycemia and other complications.

    • Medication Management and de-intensification:

      • Carevala's programs assist with medication management, including identifying opportunities for deintensification when appropriate.

      • The team works closely with providers to ensure safe and effective medication adjustments.

    • Patient Education and Empowerment:

      • Carevala provides education on hypoglycemia awareness, prevention, and management.

      • Patients are empowered to participate in their care through self-monitoring and reporting actively.

    • Care Coordination:

      • Carevala facilitates communication between patients, endocrinologists, and other healthcare professionals, ensuring coordinated care.

    • Risk Stratification:

      • Carevala can help track patient risk scores and determine which patients are at higher risk for hypoglycemic events

    Conclusion

    Traditional HbA1c-based definitions of diabetes overtreatment are inadequate for older adults. The reduction in hypoglycemic episodes provides comfort to the patient’s sleep environment. Carevala's RPM and CCM programs, incorporating CGM technology and personalized care, offer a more effective, patient-centered approach to diabetes management. This approach instills hope for improved outcomes, fostering optimism among healthcare professionals and patients alike.

    Contact Carevala to learn how to partner to empower your patients and improve outcomes.

Get started with Carevala, today.